The paradigm shifting role of chromatographic methods in pharmaceutical analysis

Journal of Pharmaceutical and Biomedical Analysis

Volumn 69, Issue , 2012, Pages 2-8

  Görög, Sándor ^a  

^a GEDEON RICHTER LTD   (Hungary)

Author keywords

GC; HPLC; Ph. Eur.; TLC; USP

Indexed keywords

MAZIPREDONE;

CHROMATOGRAPHY; COLUMN CHROMATOGRAPHY; DRUG STRUCTURE; ELECTROPHORESIS; GAS CHROMATOGRAPHY; HEALTH SURVEY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PAPER CHROMATOGRAPHY; PRIORITY JOURNAL; REVIEW; THIN LAYER CHROMATOGRAPHY; UNITED STATES;

ALBUMINS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; DRUG DESIGN; DRUG INDUSTRY; ELECTROPHORESIS; HUMANS; ISOELECTRIC FOCUSING; MODELS, CHEMICAL; PREDNISOLONE; TIME FACTORS; UNITED STATES;

EID: 84865074304     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.01.031     Document Type: Review

References (40)

1. Ettre L.S. Chapters in the Evolution of Chromatography 2008, Imperial College Press, London.
2. Chromatography A century of Discovery 1900-2000. The bridge to Sciences/Technology (Journal of Chromatography Library Volume 64) 2001, Elsevier, Amsterdam. C.W. Gehrke, R.L. Wixom, E. Bayer (Eds.).
3. Lederer M. Editorial. J. Chromatogr. 1958, 1:1.
4. Oxford Dictionaries Online, Oxford University Press, Oxford, 2011.
5. ICH Guidance for Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances, EMEA European Medicines Agency, London, May 2000.
6. Görög S. Drug safety, drug quality, drug analysis. J. Pharm. Biomed. Anal. 2008, 48:247-253.
7. The United States Pharmacopeia 16, The United States Pharmacopeial Convention, Washington, 1960.
8. The United States Pharmacopeia 34, The United States Pharmacopeial Convention, Rockville, 2011.
9. European Pharmacopoeia 7.2, Council of Europe, Strasbourg, 2011.
10. Görög S. The sacred cow: the questionable role of assay methods in characterizing the quality of bulk pharmaceuticals. J. Pharm. Biomed. Anal. 2005, 36:931-937.
11. Hofer J.D., Olsen B.A., Rickard E.C. Is HPLC assay for drug substance a useful quality control attribute?. J. Pharm. Biomed. Anal. 2007, 44:906-913.
12. Skrdla P.J., Wang T., Antonucci V., Dowling T., Ge Z., Ellison D., Curran J., Mohan G., Wyvratt J. Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols. J. Pharm. Biomed. Anal. 2009, 50:794.
13. Identification and Determination of Impurities in Drugs 2000, Elsevier, Amsterdam. S. Görög (Ed.).
14. Handbook of Isolation and Characterization of Impurities in Pharmaceuticals 2003, Elsevier, Amsterdam. S. Ahuja, K.M. Alsante (Eds.).
15. Analysis of Drug Impurities 2007, Blackwell, Oxford. R.J. Smith, M.L. Webb (Eds.).
16. Görög S. The importance and the challenges of impurity profiling in modern pharmaceutical analysis. Trends Anal. Chem. 2006, 25:755-757.
17. Bartos D., Görög S. Recent advances in the impurity profiling of drugs. Curr. Pharm. Anal. 2008, 4:215-230.
18. Huynh-Ba K. Handbook of Stability Testing in Drug Development 2008, Springer, New York.
19. Baertschi S.W. Pharmaceutical Stress Testing 2005, Taylor & Francis, London.
20. Pharmaceutical Stress Testing: Predicting Drug Degradation 2011, Informa Healthcare, London. S.W. Baertschi, K.M. Alsante, R.A. Reed (Eds.).
21. Görög S. The changing face of pharmaceutical analysis. Trends Anal. Chem. 2007, 26:12-17.
22. Planar Chromatography: A Retrospective View for the third Millenium 2001, Springer, Budapest. S. Nyiredy (Ed.).
23. Ferenczi-Fodor K., Végh Z., Renger B. Impurity profiling of pharmaceuticals by thin-layer chromatography. J. Chromatogr. A 2011, 1218:2722-2731.
24. Gritti F., Guiochon G. Performance of columns packed with the new shell Kinetex-C18 particles in gradient elution chromatography. J. Chromatogr. A 2010, 1217:1604-1615.
25. Oláh E., Fekete S., Fekete J., Ganzler K. Comparative study of new shell-type, sub-2μm fully porous and monolith stationary phases, focusing on mass-transfer resistance. J. Chromatogr. A 2010, 1217:3642-3653.
26. Guiochon G., Gritti F. Shell particles, trials, tibilations and triumphs. J. Chromatogr. A 2011, 1218:1915-1935.
27. Fekete S., Fekete J. Fast gradient screening of pharmaceuticals with 5cm long, narrow bore reversed-phase columns packed with sub-3μm core-shell and sub-2μm totally porous particles. Talanta 2011, 84:416-423.
28. Olsen B.A., Castle B.C., Myers D.P. Advances in HPLC technology for the determination of drug impurities. Trends. Anal. Chem. 2006, 25:796-805.
29. Striegel A., Yau W.W., Kirkland J.K., Bly D.D. Modern Size-Exclusion Liquid Chromatography: Practice of Gel Permeation and Gel Filtration Chromatography 2009, Wiley, New York. 2nd ed.
30. Fritz J.S., Gjerde D.T. Ion Chromatography 2009, Wiley-VCH, Weinheim. 4th ed.
31. Kolb B., Ettre L.S. Static Headspace-Gas Chromatography 2006, Wiley, New York. 2nd ed.
32. Westermeier R. Electrophoresis in Practice 2005, Wiley-VCH, Weinheim.
33. Altria K.D. Capillary Electrophoresis Handbook 2010, Humana Press, New York.
34. Chankvetadze B. Capillary Electrophoresis in Chiral Analysis 1997, Wiley, Chichester.
35. Chiral Separations by Capillary Electrophoresis 2009, CRC Press, Boca Raton. A. Van Eeckhaut, Y. Michotte (Eds.).
36. Tóth J., Tuba Z., Szporny L. Amino derivatives of 11β, 17β, 21-trihydroxy-3,20-dioxo- 1,4-pregnadiene. Nature 1961, 191:607.
37. Szporny L., Dömök L., Görög P., Fekete G. Depersolone (11β, 17β-dihydroxy-3,20 dioxo-21-N(N'-methylpiperazinyl)-1,4-pregnadiene hydrochloride) a new watersoluble glucocorticoid. Steroids 1966, 7:181-193.
38. Görög S., Tuba Z., Egyed I. Determination of 21-amino corticosteroids. Analyst 1969, 94:1044-1046.
39. Gazdag M., Babják M., Mahó S., Tuba Z., Görög S. Estimation of impurity profiles of drugs and related materials. Part 18. Impurities and degradation products of mazipredone. J. Pharm. Biomed. Anal. 1998, 17:1029-1036.
40. Görög S. New safe medicines faster: the role of analytical chemistry. Trends Anal Chem. 2003, 22:407-415.